90 related articles for article (PubMed ID: 16161753)
1. [Surveillance of susceptibility of clinical isolates to cefpodoxime between 2000 and 2003].
Abe T; Koga T; Sato Y; Ito K; Tochikawa Y
Jpn J Antibiot; 2005 Jun; 58(3):259-82. PubMed ID: 16161753
[TBL] [Abstract][Full Text] [Related]
2. [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
Abe T; Fukuoka T; Sato Y; Ito K; Sei M
Jpn J Antibiot; 2002 Dec; 55(6):827-43. PubMed ID: 12621736
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance of susceptibility of clinical isolates to panipenem between 2000 and 2003].
Abe T; Koga T; Sato Y; Ito K; Tochikawa Y
Jpn J Antibiot; 2005 Jun; 58(3):231-58. PubMed ID: 16161752
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Abe T; Fukuoka T; Sato Y; Ito K; Sei M
Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
[TBL] [Abstract][Full Text] [Related]
5. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Matsuzaki K; Yoshimori K; Shikano M; Watabe E; Sato Y; Hasegawa M; Kobayashi I; Yamanaka N
Jpn J Antibiot; 2003 Jun; 56(3):171-9. PubMed ID: 12942788
[TBL] [Abstract][Full Text] [Related]
7. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
Fenoll A; Robledo O; Lerma M; Giménez MJ; Cebrián L; Casal J; Aguilar L; Gómez-Lus ML
Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolated in major hospitals in Nagano Prefecture].
Yamazaki Y; Yagi H; Kubo K; Morita M; Hirayama J; Hayasaka M; Harada K; Honda T; Hirai K; Yanagisawa H
Jpn J Antibiot; 2002 Oct; 55(5):524-36. PubMed ID: 12532636
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
Sunakawa K; Farrell DJ
Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
[TBL] [Abstract][Full Text] [Related]
10. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
Wallrauch-Schwarz C; Milatovic D; Braveny I
Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
12. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors.
Shiro H; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
J Infect Chemother; 2015 Apr; 21(4):247-56. PubMed ID: 25596977
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
Jpn J Antibiot; 1989 Jul; 42(7):1629-66. PubMed ID: 2681864
[TBL] [Abstract][Full Text] [Related]
14. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005.
Sener B; Tunçkanat F; Ulusoy S; Tünger A; Söyletir G; Mülazimoğlu L; Gürler N; Oksüz L; Köksal I; Aydin K; Yalçin AN; Oğünç D; Acar A; Sievers J
J Antimicrob Chemother; 2007 Sep; 60(3):587-93. PubMed ID: 17597058
[TBL] [Abstract][Full Text] [Related]
15. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture].
Hachiya T; Kubo K; Yanagisawa H
Jpn J Antibiot; 2004 Apr; 57(2):157-71. PubMed ID: 15219055
[TBL] [Abstract][Full Text] [Related]
17. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States.
Hasegawa K; Yamamoto K; Chiba N; Kobayashi R; Nagai K; Jacobs MR; Appelbaum PC; Sunakawa K; Ubukata K
Microb Drug Resist; 2003; 9(1):39-46. PubMed ID: 12705682
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
19. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced.
Hasegawa K; Kobayashi R; Takada E; Ono A; Chiba N; Morozumi M; Iwata S; Sunakawa K; Ubukata K;
J Antimicrob Chemother; 2006 Jun; 57(6):1077-82. PubMed ID: 16617062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
